PT769962E - Metodo de atenuacao da estenose arterial - Google Patents
Metodo de atenuacao da estenose arterialInfo
- Publication number
- PT769962E PT769962E PT95925386T PT95925386T PT769962E PT 769962 E PT769962 E PT 769962E PT 95925386 T PT95925386 T PT 95925386T PT 95925386 T PT95925386 T PT 95925386T PT 769962 E PT769962 E PT 769962E
- Authority
- PT
- Portugal
- Prior art keywords
- atenuation
- tfpi
- hours
- arterial stenosis
- balloon angioplasty
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Excavating Of Shafts Or Tunnels (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Paper (AREA)
- Percussion Or Vibration Massage (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Devices For Medical Bathing And Washing (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27193094A | 1994-07-07 | 1994-07-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT769962E true PT769962E (pt) | 2003-07-31 |
Family
ID=23037681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT95925386T PT769962E (pt) | 1994-07-07 | 1995-07-06 | Metodo de atenuacao da estenose arterial |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0769962B1 (pt) |
JP (2) | JP4065557B2 (pt) |
AT (1) | ATE235252T1 (pt) |
AU (1) | AU2953795A (pt) |
CA (1) | CA2194443A1 (pt) |
DE (1) | DE69530084T2 (pt) |
DK (1) | DK0769962T3 (pt) |
ES (1) | ES2196067T3 (pt) |
PT (1) | PT769962E (pt) |
WO (1) | WO1996001649A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE358684T1 (de) | 1995-06-07 | 2007-04-15 | Novartis Vaccines & Diagnostic | Waessrige formulierung enthaltend tfpi und lösungsvermittlers |
AU2003200506B2 (en) * | 1995-06-07 | 2007-01-18 | G.D. Searle Llc | Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents |
CA2535562A1 (en) | 2003-08-13 | 2005-03-03 | Chiron Corporation | Improved method of purifying tfpi and tfpi analogs |
WO2008114588A1 (ja) * | 2007-03-20 | 2008-09-25 | Idemitsu Kosan Co., Ltd. | スパッタリングターゲット、酸化物半導体膜及び半導体デバイス |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0465557A (ja) * | 1990-06-28 | 1992-03-02 | Unitika Ltd | 起毛編物の製造方法 |
CA2049873C (en) * | 1990-08-27 | 2001-12-04 | Tze-Chein Wun | Anticoagulant combination of laci and sulfated polysaccharides |
US5276015A (en) * | 1992-03-18 | 1994-01-04 | Washington University | Method of inhibiting microvascular thrombosis |
KR950701820A (ko) * | 1992-06-11 | 1995-05-17 | 로저 에이. 윌리암스 | 패혈증 및 패혈증-연관 옹고장애의 예방 및 치료(prophylaxs and treatment of sepsis and sepsis-associated coagulation disorders) |
-
1995
- 1995-07-06 EP EP95925386A patent/EP0769962B1/en not_active Expired - Lifetime
- 1995-07-06 ES ES95925386T patent/ES2196067T3/es not_active Expired - Lifetime
- 1995-07-06 JP JP50434196A patent/JP4065557B2/ja not_active Expired - Fee Related
- 1995-07-06 PT PT95925386T patent/PT769962E/pt unknown
- 1995-07-06 DK DK95925386T patent/DK0769962T3/da active
- 1995-07-06 CA CA002194443A patent/CA2194443A1/en not_active Abandoned
- 1995-07-06 AU AU29537/95A patent/AU2953795A/en not_active Abandoned
- 1995-07-06 DE DE69530084T patent/DE69530084T2/de not_active Expired - Fee Related
- 1995-07-06 AT AT95925386T patent/ATE235252T1/de not_active IP Right Cessation
- 1995-07-06 WO PCT/US1995/008221 patent/WO1996001649A1/en active IP Right Grant
-
2007
- 2007-08-01 JP JP2007200356A patent/JP2008007512A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2953795A (en) | 1996-02-09 |
EP0769962A1 (en) | 1997-05-02 |
ES2196067T3 (es) | 2003-12-16 |
CA2194443A1 (en) | 1996-01-25 |
EP0769962B1 (en) | 2003-03-26 |
JPH10502639A (ja) | 1998-03-10 |
JP2008007512A (ja) | 2008-01-17 |
DE69530084D1 (de) | 2003-04-30 |
WO1996001649A1 (en) | 1996-01-25 |
DK0769962T3 (da) | 2003-06-23 |
DE69530084T2 (de) | 2004-02-05 |
JP4065557B2 (ja) | 2008-03-26 |
ATE235252T1 (de) | 2003-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT72317A (en) | Use of venflaxine or 3-aryloxi-propaneamine derivatives for preparing pharmaceutical compositions for treatment of incontinence | |
CA2238098A1 (en) | Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis | |
UA49869C2 (uk) | Нафтил-заміщені похідні бензимідазолу, фармацевтична композиція, спосіб лікування (варіанти) та спосіб інгібування людського фактора | |
CA2285389A1 (en) | Use of cytoskeletal inhibitors for the prevention of restenosis | |
EP1225168B8 (en) | Prostaglandin-F-2 alpha derivative for the treatment of glaucoma or ocular hypertension | |
ATE556705T1 (de) | Darreichungsform enthaltend taxol in kristalliner form | |
CA2125888A1 (en) | Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty | |
WO1991015222A3 (en) | Method of predisposing mammals to accelerated tissue repair | |
UA43391C2 (uk) | Спосіб інгібування міжклітинного зчеплення і спосіб інгібування запального процесу та порушеного процесу нормальної коагуляції у пацієнтів з розладами васкулярного ендотелію | |
AU631738B2 (en) | Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis | |
AU1306795A (en) | Anticonvulsant pseudofructopyranose sulfamates | |
DE69627160D1 (de) | Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma-butyrobetain für die behandlung von herz-gefäss-erkrankungen | |
PT769962E (pt) | Metodo de atenuacao da estenose arterial | |
TW325997B (en) | Pharmaceutical composition for preventing and treating retinal diseases | |
WO2003045311A3 (en) | Methods for inhibiting or suppressing stenosis of arteriovenous access fistulas and grafts | |
WO1994005296A3 (en) | Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine | |
CA2289017A1 (en) | The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer | |
DE69226487D1 (de) | Verwendung von Furanonderivaten zur Vorbeugung oder Behandlung von Autoimmunkrankheiten | |
GEP20012511B (en) | Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis | |
NO993627L (no) | Anvendelse av en forbindelse for fremstilling av et legemiddel | |
TW330933B (en) | Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes | |
MY114716A (en) | Prophylactic and/or therapeutic treatment of dyspeptic symptoms | |
GR3021171T3 (en) | Use of hyaluronic acid and forms to prevent arterial restenosis. | |
CY2525B1 (en) | Use of penciclovir for the treatment of human herpes-virus-8 | |
CA2188871A1 (en) | Method for Treating Psoriasis |